<DOC>
	<DOCNO>NCT02187536</DOCNO>
	<brief_summary>To assess pharmacokinetics simvastatin simvastatin acid with/without concomitant administration telmisartan</brief_summary>
	<brief_title>Pharmacokinetics Simvastatin Its Metabolite Simvastatin Acid With Without Concomitant Administration Telmisartan Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Healthy subject determine result screen Signed write informed consent accordance good clinical practice ( GCP ) local legislation Age ≥ 18 ≤ 55 year Broca ≥ 20 % ≤ +20 % Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Supine blood pressure screen systolic ≤ 110 mmHg diastolic ≤ 60 mmHg History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long half life ( &gt; 24 hour ) ≤ 1 month prior administration trial Use drug might influence result trial ( ≤ 10 day prior administration trial ) Participation another trial investigational drug ( 30 day prior administration trial ) Smoker Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( ≤ 1 month prior administration trial ) Excessive physical activity ( ≤ 5 day prior administration trial ) Any laboratory value outside reference range clinical relevance Hypersensitivity telmisartan and/or simvastatin and/or related class drug For female subject : Pregnancy Positive pregnancy test No adequate contraception ( e.g . sterilization , intrauterine device ( IUD ) , oral contraceptive ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>